The medical and pharmaceutical sectors are facing disruption from companies that occupy space traditionally outside of healthcare. These are companies like Apple and Google, plus an array of startups. What does this mean for the healthcare landscape?
As at 30th June 2016, Frontier IP Group Plc (LON:FIPP) have a 5% holding in Excientia
Frontier IP (LON:FIPP) unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group’s work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.
The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.